Clinical trial
Frontline Asciminib Combination in Chronic Phase CML
NCT03906292 is registered in ClinicalTrials.gov with University of Jena as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Frontline Asciminib Combination in Chronic Phase CML
- Lead sponsor
- University of Jena
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 19, 2019
- Completion date
- December 31, 2027
- Enrollment
- 125 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
chronic myeloid leukemia